Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Aug 30 2023

Full Issue

Canada Now Warns Its LGBTQ+ Travelers Of US Laws Targeting Them

Our friendly neighbors to the north are being warned of potentially unfriendly state and local laws that target LGBTQ+ people as part of an update to the travel advisory for the U.S. In other global health news, Danaher is buying a British bio reagents company that's labeled "the Amazon of antibodies."

The Washington Post: Canada Travel Advisory Warns LGBTQ People Of U.S. State Laws 

Canada has updated its travel advisory for the United States to warn LGBTQ travelers that they are at risk of being affected by state and local laws, amid a recent surge in state-level legislation targeting the community. (Li, 8/30)

Axios: Danaher Paying $5.7 Billion For The "Amazon Of Antibodies"

Danaher, a Washington, D.C.-based life sciences conglomerate, agreed to buy Abcam, a British provider of biological reagents for $5.7 billion in cash (including debt assumption). Abcam is often called the "Amazon of antibodies," and will allow Danaher to provide its lab equipment customers with a broad range of consumables. (Primack, 8/29)

Reuters: England To Rollout World-First Seven-Minute Cancer Treatment Jab 

Britain's state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters. ... "It takes approximately seven minutes, compared with 30 to 60 minutes for the current method of an intravenous infusion," Marius Scholtz, Medical Director at Roche Products Limited said. (8/29)

Noticias Telemundo for Axios: Uruguay To Offer Free Antidepressants To Combat Soaring Suicide Rate

Uruguay is tackling its staggering suicide rates by offering free antidepressants and establishing youth social and mental health centers as part of a national plan to promote wellbeing. The country's average suicide rate last year was more than double that in all of Latin America. There were 23 suicides per 100,000 people in 2022, up from 20 in 2019. The regional average last year was 9 per 100,000 people. (Franco, 8/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF